The GOLD rush

Thorax

Volumn 68, Issue 10, 2013, Pages 902-903

  Soriano, Joan B ^a  

^a Hospital Joan March   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

TERBUTALINE;

ANAMNESIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL RESEARCH; DISEASE CLASSIFICATION; DISEASE SEVERITY; EDITORIAL; FORCED EXPIRATORY VOLUME; HEALTH CARE DELIVERY; HUMAN; MORTALITY; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; SEX DIFFERENCE; SPIROMETRY;

COPD EXACERBATIONS;

FEMALE; HUMANS; LUNG; MALE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 84884596170     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2013-203595     Document Type: Editorial

References (14)

1. The Gold Rush. Directed by Charlie Chaplin. Distributed by United Artists. Release date: 26 June 1925.
2. GOLD press release. Summary handout. of a GOLD conference sponsored by the Asian Pacific Society of Respirology in Shanghai, China, 6 November 2011. http://www.goldcopd.org/uploads/users/files/ GOLD2011-Summary.pdf (accessed April 10 2013).
3. Vestbo J, Hurd SS, Agustí AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013;187:347-65.
4. Lopez-Campos JL. Treatment strategies in chronic obstructive pulmonary disease: a proposal for standardisation. Arch Bronconeumol 2010;46:617-20.
5. Leivseth L, Brumpton BM, Nilsen TIL, et al. GOLD classifications and mortality in COPD: The HUNT Study, Norway. Thorax 2013;68:914-21.
6. Lange P, Marott JL, Vestbo J, et al. Prediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classification: a study of the general population. Am J Respir Crit Care Med 2012;186:975-81.
7. Soriano JB, Alfageme I, Almagro P, et al. Distribution and prognostic validity of the new GOLD grading classification. Chest 2013;143:694-702.
8. Han MK, Muellerova H, Curran-Everett , et al. GOLD 2011 disease severity classification in COPDGene: a prospective cohort study. Lancet Respir Med 2013;1:43-50.
9. Agusti A, Edwards L, Celli B, et al. Characteristics, stability and outcomes of the GOLD 2011 COPD groups in the ECLIPSE cohort. Eur Respir J Published Online First: 13 June 2013. doi: 10.1183/ 09031936.00195212.
10. Johannessen A, Nilsen RM, Storebø M, et al. Comparison of 2011 and 2007 GOLD Guidelines for Predicting Mortality and Hospitalization. Am J Respir Crit Care Med Published Online First: 5 April 2013. doi:10.1164/rccm.201212- 2276OC
11. Pillai AP, Turner AM, Stockley RA. GOLD 2011 symptom/risk assessment in Alpha 1 antitrypsin deficiency. Chest Published Online First: 20 June 2013. doi:10.1378/chest.13-0161.
12. Vestbo J, Hurd SS, Rodriguez-Roisin R. The 2011 revision of the global strategy for the diagnosis, management and prevention of COPD (GOLD)-why and what? Clin Respir J 2012;6:208-14.
13. Miravitlles M, José Soler-Cataluña J, Calle M, et al. Treatment of COPD by clinical phenotypes. Putting old evidence into clinical practice. Eur Respir J 2013;41:1252-6.
14. Agusti A, Hurd S, Jones P, et al. Frequently asked questions (FAQ's) about the GOLD 2011 assessment proposal of COPD: A comparative analysis of four different cohorts. Eur Respir J Published Online First: 3 May 2013. doi: 10.1183/ 09031936.00036513